Skip to main content

Want a detailed portfolio tracker?

Inhibrx Biosciences (INBX) P/E (2024 - 2026)

Inhibrx Biosciences (INBX) P/E from May 29, 2024 to Jul 20, 2026. The TTM Inhibrx Biosciences (INBX) P/E is -9.39. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Inhibrx Biosciences (INBX)

YearP/EChange
2026-9.39+14.80%
2025-8.18-6276.20%
20240.13N/A

Comparison Inhibrx Biosciences (INBX) P/E with competitors

Inhibrx Biosciences (INBX) P/E is -9.39.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.80%
FGENFibroGen Inc0.24-102.56%
CHRSCoherus Biosciences Inc0.85-109.03%
FBIOFortress Biotech Inc0.95-110.10%
ORMPOramed Pharmaceuticals Inc1.50-116.00%
AGENAgenus Inc3.01-132.04%
INVAInnoviva Inc3.15-133.58%
VXRTVaxart Inc3.55-137.79%
CRMDCorMedix Inc3.63-138.63%
CVACCureVac N.V.4.45-147.33%
GLPGGalapagos NV4.86-151.73%
SRPTSarepta Therapeutics Inc4.88-151.97%
ABEOAbeona Therapeutics Inc5.39-157.36%
ABUSArbutus Biopharma Corp5.60-159.57%
ZVRAZevra Therapeutics Inc5.89-162.68%
SPROSpero Therapeutics Inc6.23-166.31%
CGENCompugen Ltd6.31-167.22%
RIGLRigel Pharmaceuticals6.87-173.16%
SLXNSilexion Therapeutics Corp7.30-177.67%
OMEROmeros Corporation9.26-198.57%
AUPHAurinia Pharmaceuticals Inc9.58-202.04%
PLXProtalix BioTherapeutics Inc10.89-215.95%
ACADAcadia Pharmaceuticals Inc11.73-224.86%
TBPHTheravance Biopharma Inc12.26-230.54%
ADMAAdma Biologics Inc12.42-232.20%
HRMYHarmony Biosciences Holdings Inc13.82-247.13%
SABSSAB Biotherapeutics Inc14.14-250.49%
NAGENiagen Bioscience Inc14.82-257.75%
INCYIncyte Corp15.82-268.45%
REGNRegeneron Pharmaceuticals Inc15.86-268.81%
PBYIPuma Biotechnology Inc17.32-284.34%
CPRXCatalyst Pharmaceuticals Inc17.44-285.66%
EXELExelixis Inc17.54-286.71%
TGTXTG Therapeutics Inc18.97-301.91%
MDXGMimedx Group Inc20.55-318.80%
XOMAXOMA Royalty Corp22.87-343.53%
ARGXArgen X SE24.30-358.68%
CTMXCytomX Therapeutics Inc24.82-364.25%
XOMAOXOMA Royalty Corp25.34-369.83%
HALOHalozyme Therapeutics Inc25.62-372.80%
XOMAPXOMA Royalty Corp25.67-373.29%
VRTXVertex Pharmaceuticals Inc27.99-398.04%
RPRXRoyalty Pharma plc - Class A28.69-405.42%
SLNOSoleno Therapeutics Inc29.02-408.91%
ASNDAscendis Pharma A/S30.09-420.30%
LGNDLigand Pharmaceuticals Inc - Class B37.91-503.62%
APLSApellis Pharmaceuticals Inc39.02-515.43%
BMRNBiomarin Pharmaceutical Inc42.21-549.40%
KRYSKrystal Biotech Inc45.34-582.74%
ONCBeiGene Ltd69.54-840.35%
PHARPharming Group N.V.75.03-898.75%
TECHBio-Techne Corp101.96-1185.48%
VCELVericel Corp109.92-1270.26%
ALNYAlnylam Pharmaceuticals Inc117.96-1355.89%
GMABGenmab140.29-1593.58%
TLXTelix Pharmaceuticals Ltd162.15-1826.33%
CORTCorcept Therapeutics Inc212.86-2366.15%